In the present study, we aimed to investigate the effects of metformin on clinical outcomes, asthma control tests (ACTs), pulmonary function tests (PFTs), BS control, and C-reactive protein (CRP) levels in patients with concurrent asthma and MetS. This evidence concerns the gene CRP and metabolic syndrome.